CHM Cannabis
Home > Boards > US OTC > Medical - Healthcare > Progressive Care, Inc. (RXMD)


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (10) | Next 10 | Previous | Next
ndww42 Member Profile
Followed By 48
Posts 2,650
Boards Moderated 0
Alias Born 10/13/14
160x600 placeholder
Progressive Care Signs Letter of Intent to Purchase Florida Based Pharmacy with $18 million in Annual Revenue InvestorsHub NewsWire - 11/28/2018 8:00:00 AM
Progressive Care Inc. Announces Record-Breaking October 2018 InvestorsHub NewsWire - 11/20/2018 4:33:06 PM
Progressive Care Inc. Reports Best Nine-Month Revenue Period in Company History in Q3 2018 Financial Filing InvestorsHub NewsWire - 11/15/2018 8:00:00 AM
Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Proprietary Tele-Pharmacy InvestorsHub NewsWire - 11/6/2018 8:00:00 AM
Progressive Care Inc. CEO to Speak at 5th Annual Florida Telehealth Summit in St. Pete Beach, Florida InvestorsHub NewsWire - 11/1/2018 8:00:00 AM
Progressive Care Enters into Definitive Agreements to Purchase Property for Third Pharmacy Location in South Florida InvestorsHub NewsWire - 10/30/2018 8:00:00 AM
Progressive Care Inc. Announces Beta Launch of New Proprietary Tele-PharmCo Software Platform for Real-Time InvestorsHub NewsWire - 10/18/2018 8:00:00 AM
Progressive Care Inc. Announces 40% Year-Over-Year Increase in Prescriptions Filled and Continued Strong Revenues in September InvestorsHub NewsWire - 10/16/2018 8:00:00 AM
Progressive Care Inc. Announces Record Number of Prescriptions Filled and Strong Revenues During August 2018 InvestorsHub NewsWire - 9/18/2018 8:00:00 AM
Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Efforts to Battle Opioid InvestorsHub NewsWire - 9/13/2018 9:47:41 AM
Progressive Care Announces Newly Redesigned Website for Wholly-Owned Subsidiary PharmCo, LLC InvestorsHub NewsWire - 9/10/2018 8:00:00 AM
S. Parikh Mars, CEO of Progressive Care Inc., is Featured in a New Audio Interview with InvestorsHub NewsWire - 8/29/2018 8:00:00 AM
Progressive Care Inc. Earns International Media Coverage in Top Industry Outlets on Its Healthcare Technology Expertise InvestorsHub NewsWire - 8/28/2018 11:05:26 AM
Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc. InvestorsHub NewsWire - 8/22/2018 8:00:00 AM
Progressive Care Inc. Reports 47% Increase in Prescriptions Filled During July 2018 MIAMI August 21, 2018 Progressive Care InvestorsHub NewsWire - 8/21/2018 8:00:00 AM
Progressive Care Inc. Reports Largest Six-Month Revenue Period in Company History in Q2 2018 Financial Filing InvestorsHub NewsWire - 8/14/2018 8:00:00 AM
Progressive Care Announces Pay-Off of Note to Chicago Venture Partners InvestorsHub NewsWire - 8/9/2018 8:00:00 AM
Progressive Care to Host Conference Call on Second Quarter 2018 Financial Results and Business Update on Aug. 14 InvestorsHub NewsWire - 8/7/2018 8:00:00 AM
Progressive Care Earns Coveted LegitScript Certification Verifying PharmCo Pharmacy is Safe and Credible Online Health Resource InvestorsHub NewsWire - 8/1/2018 8:00:00 AM
Progressive Care Subsidiary PharmCo Partners with Westchester General Hospital to Implement New DischargeRx Program InvestorsHub NewsWire - 7/26/2018 8:00:00 AM
Progressive Care Signs Two New 340B Contracts to Bring Discounted Prescription Programs to Non-Profit Healthcare Institutions InvestorsHub NewsWire - 7/19/2018 8:00:00 AM
Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018 InvestorsHub NewsWire - 7/17/2018 3:02:16 PM
Progressive Care Launches New DischargeRX Program to Improve Engagement Between Patients and Hospitals InvestorsHub NewsWire - 7/13/2018 6:20:29 PM
S. Parikh Mars, CEO of Progressive Care, Discusses Recent Company and Industry News in New Audio Interview with SmallCapVoice InvestorsHub NewsWire - 7/3/2018 4:27:48 PM
Progressive Care Completes Acquisition of Touchpoint Pharmacy Expanding Company Footprint and Market Oppotunity MIAMI July X, InvestorsHub NewsWire - 7/2/2018 12:45:32 PM
ndww42   Sunday, 03/04/18 09:27:40 AM
Re: None
Post # of 106694 

February NET revenues: Week of March 12th or 19th or sooner - should be record net revenues again with possibly our second 2M+ month.

Acquisition details: With the latest announcement of the company's intent to purchase a pharmacy in Palm Beach County, we will see additional details around this purchase and what it means on the revenue side.

Audited Annual Report: Report is due 3/31 and will be the second audited year. Having two years of audited fins is the gold standard for institutional monies to flow in.

Conference call for shareholders: This occurs every quarter. Should happen around the release of the annual report.

March Numbers: Week of April 12th or 19th - should be record revenues again with possibly our third 2M+ month.

Additional technology partnerships / contracts: Progressive care is both a healthcare services and technology company. Expect additional PRs and contracts stating new revenues streams

Institutional buying: We've had what looks to be institutional buying recently and I would venture to guess we will receive more news about institutions covering us and major investments after we have our two years of audited financials in April.

Institutional stock coverage: Shital has made it clear that she'd like to have coverage of the stock by institutional analysts. We are seeing more and more signs of this and will hear more about it soon IMO.

Online Pharmacy / e-Commerce: With the news of Bitcoin and Amazon looking to get into the pharmacy space, expect additional news on RXMD about becoming a major online pharmacy.

CBD / MJ / HEMP: One of the latest major developments. Additional news about CBD and MJ will most likely be coming out in the next couple of months. They already stated they will have in-house compounding and R&D! This will boost sales big time as customers would like to see alternatives to addictive pain pills.

Tech / Tele-Pharm news: With the latest development of this being a tech play, we should hear more about their plan for tele-Pharmco and also we should hear from our NASDAQ independent board member on the latest developments.

Investor conferences to attract institutional investors: They will most likely PR these events over the coming months.

New 340B contracts: Over the next month or two we will most likely hear about new 340B contracts from multiple partners

New Long term care facility relationships: The company continues to be active in the community with doctors, patients and long term facilities. Expect additional partnerships on this front.

Achieve accreditation for non-sterile compounding: One the company's stated goals for 2018 is receiving accreditation for non-sterile compounding. This will actually allow them to make more money with more of a backing.

Traditional financing: Expect news of traditional financing over the coming year.

Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities: Another 2018 goal of the company. They will announce more resource centers to again strengthen their relationships in the community.

More out of state licenses: They've already obtained 14 state licenses where they can do business and planning to expand to more states. We may hear more about these revenue streams as they add to the bottom line.

Purdue sales rep team: We should be hearing more about the Purdue pharma sales force to join the team for conducting out of state sales

Expansion / M&A: We should be seeing additional PBM contracts related to their recent acquisition. I also believe we will hear more about additional acquisitions and other partnerships.

NASDAQ uplisting: With traditional financing, 2 locations and a much higher PPS, I expect to start to hear more about the company's plan to uplist to NASDAQ.

RXMD - King of the OTC

Best of the Best!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (10) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist